本文選題：腎上皮樣血管平滑肌脂肪瘤 + 臨床特點(diǎn)�。� 參考：《山東大學(xué)》2017年碩士論文

【摘要】：目的:探討腎上皮樣血管平滑肌脂肪瘤的臨床特點(diǎn)、病理特點(diǎn)、診斷方法、治療及預(yù)后判斷。提高對(duì)腎上皮樣血管平滑肌脂肪瘤(EAML)的認(rèn)識(shí)及診療水平。材料及方法:本次研究我們回顧性分析了山東省立醫(yī)院泌尿外科于2017年3月3日收治的1例腎上皮樣血管平滑肌脂肪瘤患者的臨床資料�；颊吲�,37歲,因"間斷性肉眼血尿1月余"入院,當(dāng)?shù)蒯t(yī)院B超檢查示:右腎實(shí)性占位(Ca?)。CT檢查示:右腎惡性腫瘤,腫瘤體積7.3cmx9.4cmx10.5cm,腫瘤形態(tài)不規(guī)則,動(dòng)態(tài)增強(qiáng)掃描,動(dòng)脈期腫瘤強(qiáng)化不明顯,靜脈期、腎實(shí)質(zhì)期病灶明顯強(qiáng)化,但強(qiáng)化程度較正常減低,病灶與正常腎臟對(duì)比輕度強(qiáng)化。病灶突破腎周脂肪囊,突破腎盂并擠壓下腔靜脈,邊界欠清晰。腹膜后未見(jiàn)腫大淋巴結(jié)�；颊哂�2017年3月6日在氣管插管全麻下行腹腔鏡根治性右腎切除術(shù)。檢索中國(guó)知網(wǎng)和Pubmed等數(shù)據(jù)庫(kù)中關(guān)于腎EAML的文獻(xiàn)復(fù)習(xí)并討論。結(jié)果:患者于2017年3月6日行腹腔鏡下右腎根治性切除術(shù)。術(shù)后病理(病理號(hào):S1702549):(右)腎惡性上皮樣血管平滑肌脂肪瘤(11x9cm),輸尿管切線及腎門(mén)血管未查見(jiàn)腫瘤。免疫組化染色黑色素瘤相關(guān)抗原(HMB-45)強(qiáng)陽(yáng)性、MelanA陽(yáng)性。患者術(shù)后7天后恢復(fù)良好,順利出院,未行放、化療等輔助治療,隨訪至今暫未無(wú)復(fù)發(fā)及轉(zhuǎn)移。結(jié)論及意義:腎血管平滑肌脂肪瘤(AML)是一個(gè)良性的病變過(guò)程。腎上皮樣血管肌脂肪瘤(EAML)是腎臟血管肌脂肪瘤一種罕見(jiàn)的變異類(lèi)型。2004年世界衛(wèi)生組織男性和泌尿生殖系統(tǒng)腫瘤將它定義為"一種以上皮細(xì)胞為主的具有擴(kuò)散的特征的潛在的惡性間質(zhì)腫瘤"。EAML主要由類(lèi)上皮細(xì)胞、梭形細(xì)胞和巨細(xì)胞組成,不包含或只有少量的脂肪瘤的組織,其影像學(xué)檢查極易誤診為腎細(xì)胞癌或肉瘤。其治療主要依靠手術(shù)切除,因病例罕見(jiàn),研究較少,化療效果尚無(wú)肯定結(jié)論。腎EAML的確診主要依靠術(shù)后病理,尤其是免疫組織化學(xué)檢查,特征表現(xiàn)為腫瘤細(xì)胞顯示HMB-45、MelanA強(qiáng)陽(yáng)性。約有1/3發(fā)展為惡性,惡性EAML以局部浸潤(rùn)以及淋巴結(jié)轉(zhuǎn)移為主,預(yù)后總體較差。其治療手段主要為手術(shù)切除,對(duì)于化療藥物及靶向治療的研究很多,表柔比星、mTOR抑制劑依維莫司、吉西他濱等藥物短期可能有效,但長(zhǎng)期效果不明顯。隨著研究的不斷深入,可以發(fā)現(xiàn)腎EAML的可能的活躍靶點(diǎn),進(jìn)而為腎EAML輔助治療找到新方向。
[Abstract]:Objective: to investigate the clinical features, pathological features, diagnosis, treatment and prognosis of renal epithelioid angiomyolipoma. To improve the understanding and diagnosis and treatment of renal epithelioid angiomyolipoma (EAML). Materials and methods: we retrospectively analyzed the clinical data of a case of renal epithelioid angiomyolipoma treated in Urology Department of Shandong Provincial Hospital on March 3 2017. The patient was 37 years old. She was admitted to hospital because of "intermittent hematuria for more than one month." B-ultrasound examination in local hospital showed that the right renal solid space occupying place was Cajiao. Ct examination showed that the tumor volume was 7.3cmx9.4 cmx10.5cm, the shape of the tumor was irregular, and the dynamic contrast enhanced scan was performed, and the tumor size was 7.3cmx9.4 cmx10.5cm. The enhancement of tumor in arterial phase was not obvious, while in venous phase, renal parenchyma phase was obviously enhanced, but the enhancement degree was lower than that in normal stage, and the lesion was slightly enhanced compared with normal kidney. The lesion broke through the perirenal fat sac, broke through the renal pelvis and squeezed the inferior vena cava, and the boundary was unclear. No enlarged lymph nodes were seen behind the peritoneum. The patient underwent laparoscopic radical right nephrectomy under tracheal intubation and general anesthesia on March 6, 2017. To search for literature review and discussion on renal EAML in the databases of Chinese knowledge Network and Pubmed and so on. Results: laparoscopic radical nephrectomy was performed on March 6, 2017. Postoperative pathology (pathological number: S1702549% (right) malignant renal epithelioid angiomyolipoma (11 x 9 cm), ureteral tangent line and renal hilar vessel were not found. The melanoma associated antigen (HMB-45) was strongly positive and MelanA was positive. The patient recovered well 7 days after operation and was discharged smoothly, without radiotherapy, chemotherapy and other adjuvant treatment. There was no recurrence or metastasis during the follow-up. Conclusion and significance: renal angiomyolipoma (AMLA) is a benign process. Renal epithelioid angiomyolipoma (EAMLL) is a rare variant of renal angiomyolipoma. In 2004, WHO defined it as "a proliferative characteristic of epithelial cells in men and urogenital tumors." The underlying malignant interstitial neoplasms ". EAML mainly consists of epithelioid cells, A tissue consisting of spindle cells and giant cells that does not contain or contain only a small number of lipomas, and whose imaging findings are easily misdiagnosed as renal cell carcinoma or sarcoma. Its treatment mainly depends on surgical resection, because the case is rare, the research is less, the chemotherapeutic effect does not have the definite conclusion. The diagnosis of renal EAML mainly depends on postoperative pathology, especially immunohistochemical examination, which is characterized by tumor cells showing strong positive for HMB-45 and Melan A. About one third of the patients developed malignancy, and local invasion and lymph node metastasis were dominant in malignant EAML, and the prognosis was generally poor. Surgical resection is the main treatment method. There are many studies on chemotherapeutic drugs and targeted therapy. Evimoxus and gemcitabine inhibitors of epirubicin may be effective in the short term, but the long-term effect is not obvious. With the development of research, the possible active target of renal EAML can be found, and a new direction for renal EAML adjuvant therapy can be found.
【學(xué)位授予單位】：山東大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類(lèi)號(hào)】：R737.11

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;Hepatic angiomyolipoma-misdiagnosis as hepatocellular carcinoma:A report of 14 cases[J];World Journal of Gastroenterology;2000年04期

2 ;Diagnostic analysis of hepatic angiomyolipoma[J];Hepatobiliary & Pancreatic Diseases International;2005年01期

3 Masahiro Takahara;Yasuhiro Miyake;Kazuyuki Matsumoto;Daisuke Kawai;Eisuke Kaji;Tatsuya Toyokawa;Morihito Nakatsu;Masaharu Ando;Mamoru Hirohata;;A case of hepatic angiomyolipoma difficult to distinguish from hepatocellular carcinoma[J];World Journal of Gastroenterology;2009年23期

4 Alan M Hawxby;Michael Torbenson;Elliot Fishman;Leo Lawler;Luis M Arrazola;Andrew S Klein;;Juxta-caval hepatic angiomyolipoma masquerading as hepatocellular carcinoma[J];Hepatobiliary & Pancreatic Diseases International;2003年04期

5 ;Diagnosis and treatment of hepatic angiomyolipoma in 26 cases[J];World Journal of Gastroenterology;2003年08期

6 ;Clinical features of hepatic angiomyolipoma[J];Hepatobiliary & Pancreatic Diseases International;2008年03期

7 ;Epithelioid angiomyolipoma of the liver:Cross-sectional imaging findings of 10 immunohistochemically-verified cases[J];World Journal of Gastroenterology;2009年36期

8 紀(jì)元,許建芳,譚云山,周燕南,朱雄增,王堅(jiān),周儉,樊嘉;Hepatic angiomyolipoma: a clinicopathologic study of 10 cases[J];Chinese Medical Journal;2001年03期

9 ;Hepatic angiomyolipoma: Dynamic computed tomography features and clinical correlation[J];World Journal of Gastroenterology;2009年27期

10 ;Value of Apparent Diffusion Coefficient(ADC) of Diffusion eighted Magnetic Resonance Imaging in Common Renal Disease Diagnosis[J];Journal of Nanjing Medical University;2008年06期

相關(guān)會(huì)議論文 前3條

1 ;Clear cell renal cell carcinoma:differentiation from angiomyolipoma on contrast-enhanced ultrasonography[A];第二屆長(zhǎng)三角超聲醫(yī)學(xué)論壇暨2009年浙江省超聲醫(yī)學(xué)學(xué)術(shù)年會(huì)論文匯編[C];2009年

2 蔣s，

本文編號(hào)：1957738